Boston Assoc To Stop Treatment is categorized under Outpatient Services in Cambridge, MA and active since 1994.
Boston Assoc To Stop Treatment was established in 1994, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Outpatient Services business, which does work in the B2C market, and is classified as a Outpatient Services, under code number 621420 by the NAICS.
If you are seeking more information, feel free to contact Estelle Disch at the company’s single location by writing to 528 Franklin St, Cambridge, Massachusetts MA 02139 or by phoning (989) 343-2250. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Boston Assoc To Stop Treatment |
| Contact Person: | Estelle Disch |
| Address: | 528 Franklin St, Cambridge, Massachusetts 02139 |
| Phone Number: | (989) 343-2250 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Services |
| SIC Code: | 8093 |
| NAICS Code: | 621420 |
| Share This Business: |
Boston Assoc To Stop Treatment was started in 1994 to provide professional Outpatient Services under the SIC code 8093 and NAICS code 621420. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Estelle Disch for inquiries that concern Boston Assoc To Stop Treatment by calling the company number (989) 343-2250, as your correspondence is most welcome. Additionally, the physical location of the single location of Boston Assoc To Stop Treatment can be found at the coordinates 42.367733,-71.111429 as well as the street address 528 Franklin St in Cambridge, Massachusetts 02139.
For its online presence, you may visit Boston Assoc To Stop Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.